¼¿ï¾Æ»êº´¿ø ÀÌÁÖ¿ë, ÀÌÈñ¶õ ±³¼öÆÀ°ú °øµ¿ ¿¬±¸
ÁÖÁ¦ : Ç÷û°ú À¯¸®Ã¼¾×ÀÇ ¾Æµ¥³ëºÎ¼Ó¹ÙÀÌ·¯½º¿¡ ´ëÇÑ ÁßÈÇ×ü ³óµµÀÇ »ó°ü¼º¿¡ ´ëÇÑ ¿¬±¸ – À¯ÀüÀÚ Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâ (Relationship between neutralizing antibodies against adeno-associated virus in the vitreous and serum: affects on retinal gene therapy)
³»¿ë : À¯¸®Ã¼¾× ³»ÀÇ ¾Æµ¥³ëºÎ¼Ó¹ÙÀÌ·¯½º¿¡ ´ëÇÑ ÁßÈÇ×ü ³óµµ¸¦ ÃÖÃÊ·Î ÃøÁ¤ÇÑ ¿¬±¸·Î ¸Á¸·ÁúȯÀÇ Ç÷¾×-¸Á¸· À庮ÀÇ ¼Õ»ó ¿©ºÎ¿¡ µû¶ó Ç÷û¿¡¼ÀÇ ³óµµ¿Í ´Ù¸¥ »ó°ü¼ºÀ» º¸ÀÏ ¼ö ÀÖÀ½À» ¹àÇô ÇâÈÄ ¸Á¸·ÁúȯÀÇ À¯ÀüÀÚ Ä¡·á½Ã ȯÀÚ ¼±º°À» À§ÇÑ Áß¿äÇÑ Åä´ë°¡ µÇ´Â ³í¹®ÀÌ´Ù.